RainDance Technologies Announces First Commercial Shipment of RDT 1000, Sequence Enrichment Solution; Delivery to Ontario Institute for Cancer Research

LEXINGTON, Mass.--(BUSINESS WIRE)--RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, today announced the first commercial shipment of its RDT 1000 and Sequence Enrichment Solution. The shipment will be delivered to the Ontario Institute for Cancer Research in Canada (OICR), a new, innovative institute dedicated to research in the prevention, early detection, diagnosis and treatment of cancer.
MORE ON THIS TOPIC